Sino Medical Sciences Technology Inc. (SHA:688108)
21.85
+1.51 (7.42%)
Apr 1, 2026, 3:00 PM CST
SHA:688108 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 396.41 | 291.67 | 188.64 | 203.42 | 287.76 |
Cash & Short-Term Investments | 396.41 | 291.67 | 188.64 | 203.42 | 287.76 |
Cash Growth | 35.91% | 54.62% | -7.27% | -29.31% | -47.18% |
Accounts Receivable | 25.14 | 7.47 | 8.94 | 20.28 | 12 |
Other Receivables | 6.3 | 11.42 | 0.49 | 0.53 | 0.86 |
Receivables | 31.45 | 18.9 | 9.43 | 20.82 | 12.86 |
Inventory | 88.79 | 89.51 | 118.22 | 98.13 | 84.88 |
Prepaid Expenses | - | 0 | 0.01 | - | - |
Other Current Assets | 3.74 | 3.31 | 27.88 | 32.54 | 45.3 |
Total Current Assets | 520.39 | 403.39 | 344.18 | 354.9 | 430.8 |
Property, Plant & Equipment | 108.68 | 135.79 | 165.95 | 176.77 | 172.58 |
Long-Term Investments | - | - | 14 | 18.95 | 33.65 |
Goodwill | 46.22 | 46.22 | - | - | - |
Other Intangible Assets | 170.53 | 189.31 | 53.4 | 52.87 | 73.92 |
Long-Term Deferred Tax Assets | 85.59 | 111.88 | 105.33 | 91.78 | 44.17 |
Long-Term Deferred Charges | 417.79 | 413.88 | 375.91 | 369.2 | 333.07 |
Other Long-Term Assets | 0.48 | 0.08 | 127.05 | 3.14 | 14.89 |
Total Assets | 1,350 | 1,301 | 1,186 | 1,068 | 1,103 |
Accounts Payable | 33.03 | 13.94 | 20.12 | 13.41 | 8.57 |
Accrued Expenses | 33.97 | 70.64 | 57.65 | 62.19 | 55.18 |
Short-Term Debt | 48.44 | 53.05 | 53.55 | 35.54 | 5.01 |
Current Portion of Long-Term Debt | 148.46 | 4.56 | 0.76 | - | - |
Current Portion of Leases | - | 11.51 | 14.96 | 10.95 | 11.78 |
Current Income Taxes Payable | 8.27 | 0.02 | - | - | - |
Current Unearned Revenue | 1.59 | 1.87 | 1.12 | 0.79 | 0.41 |
Other Current Liabilities | 59.99 | 36.43 | 3.12 | 9.3 | 11.6 |
Total Current Liabilities | 333.75 | 192.02 | 151.27 | 132.18 | 92.56 |
Long-Term Debt | - | 137 | 105.3 | - | - |
Long-Term Leases | 14.83 | 18.99 | 24.92 | 11.83 | 27.49 |
Long-Term Unearned Revenue | 5.7 | 13.32 | 21 | 2 | 1.94 |
Long-Term Deferred Tax Liabilities | 35.56 | 40.89 | 20.22 | 22.72 | 21.47 |
Other Long-Term Liabilities | - | - | 1.46 | 11.4 | 14.47 |
Total Liabilities | 389.84 | 402.22 | 324.17 | 180.13 | 157.92 |
Common Stock | 416.05 | 413.46 | 410 | 410 | 410 |
Additional Paid-In Capital | 663.36 | 651.98 | 608.92 | 596.87 | 527.37 |
Retained Earnings | -152.15 | -199.44 | -200.94 | -161.31 | -8.44 |
Comprehensive Income & Other | 0.39 | 0.89 | 1.97 | 1.52 | -1.09 |
Total Common Equity | 927.64 | 866.89 | 819.96 | 847.08 | 927.84 |
Minority Interest | 32.18 | 31.45 | 41.69 | 40.4 | 17.33 |
Shareholders' Equity | 959.83 | 898.34 | 861.65 | 887.48 | 945.16 |
Total Liabilities & Equity | 1,350 | 1,301 | 1,186 | 1,068 | 1,103 |
Total Debt | 211.73 | 225.11 | 199.49 | 58.31 | 44.27 |
Net Cash (Debt) | 184.68 | 66.56 | -10.85 | 145.11 | 243.48 |
Net Cash Growth | 177.44% | - | - | -40.40% | -55.31% |
Net Cash Per Share | 0.43 | 0.18 | -0.03 | 0.36 | 0.60 |
Filing Date Shares Outstanding | 452.42 | 413.46 | 410 | 410 | 410 |
Total Common Shares Outstanding | 452.42 | 413.46 | 410 | 410 | 410 |
Working Capital | 186.64 | 211.37 | 192.9 | 222.72 | 338.24 |
Book Value Per Share | 2.05 | 2.10 | 2.00 | 2.07 | 2.26 |
Tangible Book Value | 710.9 | 631.36 | 766.55 | 794.21 | 853.92 |
Tangible Book Value Per Share | 1.57 | 1.53 | 1.87 | 1.94 | 2.08 |
Machinery | - | 265.54 | 286 | 278.74 | 226.45 |
Construction In Progress | - | 1.17 | 1.55 | 6.66 | 11.92 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.